Author | Emily Kaiser


Weekly review in ophthalmology: 29 October-3 November

An end-of-week review of what happened in ophthalmology from 29 October to 3 November 2022.

Disrupting the glaucoma treatment paradigm with novel femtosecond laser from ViaLase

Shawn O'Neil of ViaLase shares updates on the company's femtosecond laser, image-guided, high-precision trabeculotomy (FLigHT) treatment.

Trukera Medical rebranding ushers in new era of expansion into cornea market

Adam Szaronos, President and CEO of Trukera Medical, discusses the recent rebranding of TearLab as well as the launch of the ScoutPro Osmolarity System.